Mixed-effects models for slope-based endpoints in clinical trials of chronic kidney disease.
Sign Up to like & getrecommendations! Published in 2019 at "Statistics in medicine"
DOI: 10.1002/sim.8282
Abstract: In March of 2018, the National Kidney Foundation, in collaboration with the US Food and Drug Administration and the European Medicines Agency, sponsored a workshop in which surrogate endpoints other than currently established event-time endpoints… read more here.
Keywords: kidney; slope based; endpoints clinical; clinical trials ... See more keywords